Dysfunctional leadership, Severe Turnover, Immature Product, Toxic Culture
Pros
Interesting time in the market for oncology data analytics Good work life balance
Cons
Very dysfunctional executive team that does not get along; weak CEO (former banker) who lacks experience in healthcare & tech industry and struggles to establish strategy and execute on product roadmap Key talent in Product, BD and Engineering have left; large amounts of turnover (over 30%) at highest level of organization (over 8 Exec/SVP/VP in the last 12 months) due to lack of strategy, defined products and toxic culture Highest turnover in BD due to difficulty selling products that are far from market ready; mgt does not honor bonus commitments Poorly resourced product/engineering team due to insufficient resourcing, resulting in ill-defined, immature and unscalable products Toxic culture created from very top heavy dysfunctional executive team, making day to day work a miserable... Overall, a lot of smoke and mirrors....
